• Home
  • About Us
    • Overview
    • Alumni
    • Study With Us
  • Research
    • Biobank/Biomarkers
    • Bioinformatics/Systems Biology
    • Genomics Sequencing
    • Imaging: Human & Mouse
    • Mouse Models
    • Novel Therapies
    • Tumour Immunology
  • News and Resources
    • Patient and Family Information
    • Clinical Trials
    • Asbestos Review Program
    • NCARD Publications
    • News
  • Contact Us
DONATE
  • Home
  • About Us
    • Overview
    • Study With Us
    • Vision
    • Research Leaders
    • Consumer Panel
  • Research
    • Biobank/Biomarkers
    • Bioinformatics/Systems Biology
    • Genomics Sequencing
    • Imaging: Human & Mouse
    • Mouse Models
    • Novel Therapies
    • Tumour Immunology
  • News and Resources
    • Patient and Family Information
    • Clinical Trials
    • Asbestos Review Program
    • NCARD Publications
    • News
  • Contact Us
  • Donate
NCARD researchers discover blood markers that may predict mesothelioma treatment success

NCARD researchers discover blood markers that may predict mesothelioma treatment success

News, Publications
6 months ago
A groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research has identified blood markers…

Trial increases survival rates for mesothelioma patients

News, Publications
1 year ago
A breakthrough clinical trial has found that combining a new drug with chemotherapy treatment improved survival rates of malignant mesothelioma patients. The study, published in JAMA Oncology, was led by…

Neo-antigen specific T cell responses indicate the presence of metastases before imaging

Publications
6 years ago

Bibliometric analysis of gaps in research on asbestos-related diseases: declining emphasis on public health over 26 years

Publications
7 years ago

Combination immune checkpoint blockade as an effective therapy for mesothelioma

Publications
7 years ago

Transient Treg depletion enhances therapeutic anti-cancer vaccination

Publications
9 years ago
National Centre for Asbestos Related Diseases

NCARD researchers are recognised as world leaders. We have an extensive collaborative network with leading researchers across the globe.

NCARD is part of the University of Western Australia (UWA) and Institute for Respiratory Health (IRH).

Latest News

Recent Posts

  • NCARD Secures Funding for Innovative Mesothelioma Imaging Study May 16, 2025
  • NCARD secures $500K for international mesothelioma research consortium May 2, 2025
  • Boosting immunotherapy: NCARD researcher receives Tour de Cure grant April 4, 2025
  • NCARD at iMig 2025: Advancing global collaboration in mesothelioma research March 17, 2025
Scientific Publications

NCARD researchers have published hundreds of peer-reviewed articles on mesothelioma and related research. Visit our Scientific Publications page to see papers from the last several years.

Subscribe

Keep in touch by subscribing to the NCARD newsletter.

Contacts
ncard-research@uwa.edu.au
(08) 6151 1078

QQ Block
QEII Medical Campus
6 Verdun Street
Nedlands
6009

Designed by Redhead Digital Marketing